京新药业(002020.SZ):拟终止回购公司股份 已回购1936.42万股将予以注销
格隆汇 9 月 11日丨京新药业(002020.SZ)公布,2020年9月11日,公司召开第七届董事会第十五次会议,审议通过了《关于终止回购公司股份的议案》,为推进公司2020年度非公开发行A股股票事项的实施,同意公司提前终止回购公司股份事项。议案还需提交公司股东大会审议通过后方可实施。
鉴于《深圳证券交易所上市公司回购股份实施细则》第二十条的规定:上市公司在回购期间不得发行股份募集资金,但依照有关规定发行优先股的除外。公司已于2020年7月14日披露《2020年非公开发行股票预案》,并于2020年7月28日披露《2020年非公开发行股票预案(修订稿)》,为顺利推进本次非公开发行股票事宜,公司董事会经与中介机构、法律顾问进行审慎研究后决定提前终止本次回购公司股份事项。
根据《深圳证券交易所股票上市规则》、《深圳证券交易所上市公司回购股份实施细则》等法律、法规及规范性文件的有关规定,本次提前终止回购股份事项还需提交公司股东大会审议通过后方可实施。
根据公司《回购部分社会公众股方案》,公司本次已回购股份1936.4224万股将予以注销并减少公司注册资本,公司股本将由7.24872亿股变更为7.05507776亿股,注册资本将由7.24872亿元变更7.05507776亿元。公司将根据后续进展情况及时履行信息披露义务,敬请投资者注意投资风险。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.